Overview
Status
Active
Registry date
2016-06-22
Share capital
5,000.00 PLN
Registered address
ul. Gen. Józefa Zajączka 26, 01-510 Warszawa, Poland
Electronic delivery address
AE:PL-63828-50979-EDEES-23
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
- Other professional, scientific and technical activities n.e.c (74.9)
Authorized Representatives
Robert Aleksandrowicz – Vice President of the Management Board
Magdalena Król – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Aleksandrowiczage 60 | 10 | $135.06 | 10% |
Maciej Białasekage 37 | 10 | $135.06 | 10% |
Magdalena Królage 45 | 70 | $945.43 | 70% |
Bartłomiej Taciakage 37 | 10 | $135.06 | 10% |
Beneficial owners
No beneficial owners recorded for the company Orveya.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-29 | Address change (Ul. Pory 78, 02-757, Warszawa → Ul. Gen. Józefa Zajączka 26, 01-510, Warszawa) | |
| 2025-09-29 | Name change (K&r Consulting → Orveya) | |
| 2025-09-29 | Switch to PKD 2025 (10 PKD 2007 codes → 3 PKD 2025 codes) | |
| 2016-06-22 | Entered in the register |
FAQ
The main business activity of Orveya focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on June 22, 2016.
The headquarters is located at: ul. Gen. Józefa Zajączka 26, 01-510 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-03-21